Predictors of bone biomarkers in children and adolescents with Crohn disease
Tuchman, S, Thayu, M, Zemel, B.S, Burnham, J.M, Leonard, M.B
Published in Bone (New York, N.Y.) (01.06.2007)
Published in Bone (New York, N.Y.) (01.06.2007)
Get full text
Journal Article
Improvement in a biomarker of bone formation during infliximab therapy in pediatric Crohn disease: Results of the REACH study
Thayu, M, Leonard, M, Hyams, J, Crandall, W, Kugathasan, S, Otley, A, Olsen, A, Xu, S, Marano, C, Heuschkel, R, Veereman-Wauters, G, Griffiths, A, Baldassano, R, REACH Study Group
Published in Bone (New York, N.Y.) (01.06.2007)
Published in Bone (New York, N.Y.) (01.06.2007)
Get full text
Journal Article
MA13.06 Amivantamab, Lazertinib Plus Platinum-based Chemotherapy in EGFR-mutated Advanced NSCLC: Updated Results from CHRYSALIS-2
Lee, S.-H., Cho, B.C., Spira, A.I., Ou, S.-H.I., Waqar, S.N., Shah, S., Trani, L., Chu, P.-L., Thayu, M., Knoblauch, R.E., Bauml, J.M., Marmarelis, M.E.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
MA07.04 Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy in Relapsed/Refractory EGFR-mutant NSCLC
Marmarelis, M.E., Lee, S.-H., Spira, A.I., Ou, S.-H.I., Waqar, S., Li, S., Thayu, M., Knoblauch, R.E., Bauml, J.M., Cho, B.C.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
20P Risk and management of intracranial progression on amivantamab in epidermal growth factor receptor (EGFR) exon 20 insertion (ex20ins)-mutated non-small cell lung cancer (NSCLC)
Trigo, J., Cho, B.C., Park, K., Girard, N., Viteri, S., Garrido, P., Krebs, M.G., Thayu, M., Knoblauch, R.E., Xie, J., Bauml, J.M., Schnepp, R.W., Londhe, A., Mahadevia, P., Leighl, N.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
1193MO Amivantamab plus lazertinib in post-osimertinib, post-platinum chemotherapy EGFR-mutant non-small cell lung cancer (NSCLC): Preliminary results from CHRYSALIS-2
Shu, C.A., Goto, K., Ohe, Y., Besse, B., Park, K., Wang, Y., Griesinger, F., Yang, J.C-H., Felip, E., Sanborn, R.E., Caro, R. Bernabe, Bauml, J.M., Chen, J., Fennema, E., Mahoney, J., Trani, L., Knoblauch, R.E., Thayu, M., Cho, B.C.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
1247P Management of infusion-related reactions (IRRs) in patients receiving amivantamab
Park, K., Sabari, J.K., Haura, E.B., Shu, C.A., Spira, A., Salgia, R., Reckamp, K.L., Sanborn, R.E., Govindan, R., Bauml, J.M., Curtin, J.C., Xie, J., Roshak, A., Lorenzini, P., Millington, D., Thayu, M., Knoblauch, R.E., Cho, B.C.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
P1.16-01 Amivantamab and Lazertinib in Treatment-Naive EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Cho, B.C., Lee, S.-H., Han, J.-Y., Cho, E.K., Lee, J.-S., Lee, K.H., Curtin, J.C., Gao, G., Xie, J., Schnepp, R.W., Bauml, J.M., Knoblauch, R.E., Thayu, M., Kim, D.-W.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
EP08.02-016 Frontline and Post-Osimertinib Therapy for EGFR-mutant Advanced NSCLC: Treatment Patterns, Outcomes, Healthcare Use and Costs
Girard, N., Besse, B., Bernabé Caro, R., Goto, K., Leighl, N., Ohe, Y., Sabari, J., Lee, S-h., Lin, X., Schaeffer, M., Nair, S., Li, T., Di Scala, L., Potluri, R., Mahadevia, P., Thayu, M., Kim, T.M.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article
30 Long-term efficacy, safety, and predictors of response to amivantamab among patients with post-platinum EGFR Ex20ins-mutated advanced NSCLC
Lopez, P. Garrido, Girard, N., Cho, B.C., Sabari, J., Spira, A., Sanborn, R.E., Goto, K., Yang, J.C-H., Curtin, J., Lyu, X., He, A., Penton, J., Edwards, J., Massin, G. Low, Xia, K., Chioda, M., Thayu, M., Knoblauch, R.E., Mahadevia, P., Leighl, N.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
OA15.03 Amivantamab in Non-small Cell Lung Cancer (NSCLC) with MET Exon 14 Skipping (METex14) Mutation: Initial Results from CHRYSALIS
Spira, A., Krebs, M., Cho, B.C., Besse, B., Goldman, J., Janne, P., Lee, C.K., Ma, Z., Mansfield, A., Minchom, A., Ou, S., Salgia, R., Wang, Z., Gao, G., Curtin, J., Roshak, A., Schnepp, R., Thayu, M., Knoblauch, R., Trigo, J.M.
Published in Journal of thoracic oncology (01.10.2021)
Published in Journal of thoracic oncology (01.10.2021)
Get full text
Journal Article
OA21.04 Amivantamab in Patients with Advanced NSCLC and MET Exon 14 Skipping Mutation: Results from the CHRYSALIS Study
Leighl, N., Cho, B.C., Hiret, S., Han, J.-Y., Lee, K.H., Llacer Perez, C., Krebs, M.G., De Braud, F., Haura, E., Sanborn, R.E., Yang, J.C.-H., Shu, C.A., Goto, K., Nishio, M., Zhao, J., Wang, Z., Tomasini, P., Felip, E., Goldman, J.W., Ou, S.-H.I., Boyer, M., Gao, G., Qu, S., Curtin, J.C., Lyu, X., Roshak, A., Schnepp, R.W., Kim, P., Mertz, J., Thayu, M., Shreeve, S.M., Knoblauch, R.E., Spira, A.I.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
1192MO Amivantamab monotherapy and in combination with lazertinib in post-osimertinib EGFR-mutant NSCLC: Analysis from the CHRYSALIS study
Leighl, N.B., Shu, C.A., Minchom, A., Felip, E., Cousin, S., Cho, B.C., Park, K., Han, J-Y., Boyer, M., Lee, C.K., Garcia, V. Moreno, Tomasini, P., Viteri, S., Xie, J., Mertz, J., Artis, E., Schnepp, R.W., Knoblauch, R.E., Thayu, M., Perez, J.M. Trigo
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
P1.01-94 JNJ-61186372, an EGFR-cMet Bispecific Antibody, in EGFR Exon 20 Insertion-Driven Advanced NSCLC
Yun, J., Kang, H.N., Lee, S., Park, C., Jeong, S., Hong, M.H., Kim, H.R., Thayu, M., Curtin, J.C., Knoblauch, R.E., Lorenzi, M.V., Roshak, A., Cho, B.C.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
1258O Amivantamab (JNJ-61186372), an EGFR-MET bispecific antibody, in combination with lazertinib, a 3rd-generation tyrosine kinase inhibitor (TKI), in advanced EGFR NSCLC
Cho, B.C., Lee, K.H., Cho, E.K., Kim, D-W., Lee, J-S., Han, J-Y., Kim, S-W., Spira, A., Haura, E.B., Sabari, J.K., Sanborn, R.E., Bauml, J.M., Gomez, J.E., Lorenzini, P., Infante, J.R., Xie, J., Haddish-Berhane, N., Thayu, M., Knoblauch, R.E., Park, K.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Skeletal Health of Children and Adolescents With Inflammatory Bowel Disease
Published in Journal of pediatric gastroenterology and nutrition
(01.04.2012)
Get full text
Journal Article
OA04.04 Amivantamab in Post-platinum EGFR Exon 20 Insertion Mutant Non-small Cell Lung Cancer
Sabari, J.K., Shu, C.A., Park, K., Leighl, N., Mitchell, P., Kim, S., Lee, J., Kim, D., Viteri, S., Spira, A., Han, J., Trigo, J., Lee, C.K., Lee, K.H., Girard, N., Yang, T., Goto, K., Sanborn, R.E., Yang, J.C., Xie, J., Roshak, A., Thayu, M., Knoblauch, R.E., Cho, B.C.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
P-112: The association between drug levels, anti-drug antibodies, and therapeutic response during infliximab therapy in pediatric Crohn’s disease
Stein, R.E., Lee, D.Y., Leonard, M.B., Thayu, M., Herskovitz, R.M., Kerbowski, T., Baldassano, R.N.
Published in Journal of Crohn's and colitis (01.09.2014)
Published in Journal of Crohn's and colitis (01.09.2014)
Get full text
Journal Article